Dermata Therapeutics Correlations
DRMA Stock | USD 1.16 0.08 7.41% |
The current 90-days correlation between Dermata Therapeutics and ZyVersa Therapeutics is 0.15 (i.e., Average diversification). The correlation of Dermata Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Dermata Therapeutics Correlation With Market
Average diversification
The correlation between Dermata Therapeutics and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Dermata |
Moving together with Dermata Stock
0.65 | DYN | Dyne Therapeutics | PairCorr |
0.73 | XFOR | X4 Pharmaceuticals | PairCorr |
0.63 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.78 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.62 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
0.72 | INZY | Inozyme Pharma | PairCorr |
0.79 | KURA | Kura Oncology | PairCorr |
0.7 | PALI | Palisade Bio | PairCorr |
0.72 | BDRX | Biodexa Pharmaceticals Upward Rally | PairCorr |
0.61 | TERN | Terns Pharmaceuticals | PairCorr |
0.67 | PPERY | Bank Mandiri Persero | PairCorr |
Moving against Dermata Stock
0.66 | EWTX | Edgewise Therapeutics | PairCorr |
0.66 | PRAX | Praxis Precision Med | PairCorr |
0.63 | AMLX | Amylyx Pharmaceuticals | PairCorr |
0.56 | AKRO | Akero Therapeutics | PairCorr |
0.51 | ALVO | Alvotech | PairCorr |
0.39 | VRDN | Viridian Therapeutics | PairCorr |
0.32 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.72 | SSNLF | Samsung Electronics | PairCorr |
0.7 | PTAIF | PT Astra International | PairCorr |
0.69 | WMT | Walmart Aggressive Push | PairCorr |
0.66 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
0.65 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
0.64 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.61 | T | ATT Inc Aggressive Push | PairCorr |
0.6 | HPQ | HP Inc | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Dermata Stock performing well and Dermata Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Dermata Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
KPRX | 2.77 | (0.29) | 0.00 | (0.26) | 0.00 | 5.95 | 16.59 | |||
ZVSA | 4.67 | (0.99) | 0.00 | 0.60 | 0.00 | 9.17 | 78.93 | |||
SONN | 4.76 | (0.77) | 0.00 | 2.19 | 0.00 | 12.31 | 37.58 | |||
ZURA | 3.78 | (0.36) | 0.00 | (0.09) | 0.00 | 7.95 | 30.69 | |||
PHIO | 4.53 | (0.30) | 0.00 | (0.18) | 0.00 | 11.78 | 36.22 | |||
RNAZ | 7.63 | 1.05 | 0.10 | (0.44) | 6.52 | 22.00 | 68.80 | |||
QNRX | 6.21 | 0.47 | 0.07 | 0.37 | 6.73 | 17.65 | 74.46 |
Dermata Therapeutics Corporate Management
Maria MBA | Senior Assurance | Profile | |
Gerald Proehl | President, Founder | Profile | |
Sean Proehl | Senior Development | Profile | |
David Hale | CoFounder Director | Profile | |
Dr MPH | Senior Officer | Profile |